LINC02011

Across TCGA pan-cancer cohorts, LINC02011 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02011 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC02011 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02011 expression acts as an unfavorable survival marker, although some lineages such as COAD and KIRP show a favorable association.

STAD, LUAD, and MESO are the cancer types where LINC02011 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Quartile	All	0.434	0.608	.002	95	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	69	view →
MESO	DFS	Tertile	III,IV	0.203	0.438	.011	54	view →
COAD	OS	Quartile	III,IV	0.851	0.634	.007	54	view →
UCEC	DFS	Tertile	All	0.515	0.674	.001	48	view →
UVM	DFS	Tertile	All	0.281	0.605	.004	36	view →
OV	OS	Median	IV	0.604	0.887	.005	28	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	28	view →
PAAD	OS	Quartile	All	0.425	0.652	.015	27	view →
KIRP	DFS	Median	III,IV	0.619	0.154	.002	21	view →
LUSC	DFS	Tertile	III,IV	0.121	0.821	<.001	21	view →
BLCA	DFS	Tertile	All	0.568	0.231	.036	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02011–STAD (DFS)

Open the STAD breakdown →